HRMY - CIK 0001802665
The table below shows Harmony Biosciences Holdings, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $752.50M | $453.00M | $311.66M | $243.78M | $234.31M | $228.63M |
| Short-term investments | $22.84M | $14.19M | $41.80M | $79.33M | - | - |
| Receivables | $96.79M | $83.03M | $74.14M | $54.74M | $34.84M | $22.18M |
| Inventory | $5.36M | $7.20M | $5.36M | $4.30M | $4.43M | $3.82M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $907.01M |
| $579.25M |
| $451.07M |
| $400.29M |
| $284.44M |
| $262.89M |
| Property, plant & equipment | - | $1.26M | $371.00K | $573.00K | $820.00K | $938.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.27B | $999.20M | $811.45M | $673.87M | $433.44M | $427.07M |
| Accounts payable | $17.69M | $13.74M | $17.73M | $3.79M | $1.00M | $2.56M |
| Total current liabilities | $252.13M | $175.08M | $163.78M | $78.88M | $53.77M | $134.54M |
| Long-term debt | $143.66M | $163.02M | $178.57M | $189.65M | $189.98M | $194.25M |
| Total liabilities | $401.41M | $340.05M | $344.46M | $271.03M | $246.94M | $329.89M |
| Retained earnings | $160.90M | $2.22M | -$143.28M | -$272.13M | -$453.60M | -$488.19M |
| Total equity | $870.22M | $659.15M | $466.99M | $402.84M | $186.51M | $97.18M |